Polyclonal Rabbit anti‑Human MAPKAPK2 / MAPKAP Kinase 2 Antibody (AP, phospho‑Thr334, WB) LS‑C411601
Polyclonal Rabbit anti‑Human MAPKAPK2 / MAPKAP Kinase 2 Antibody (AP, phospho‑Thr334, WB) LS‑C411601
Antibody:
MAPKAPK2 / MAPKAP Kinase 2 Rabbit anti-Human Polyclonal (pThr334) (AP) Antibody
Format:
Alkaline Phosphatase, Unmodified
Overview
Antibody:
MAPKAPK2 / MAPKAP Kinase 2 Rabbit anti-Human Polyclonal (pThr334) (AP) Antibody
Format:
Alkaline Phosphatase, Unmodified
Specifications
Description
MAPKAP Kinase 2 antibody LS-C411601 is an AP-conjugated rabbit polyclonal antibody to human MAPKAP Kinase 2 (MAPKAPK2) (pThr334). Validated for WB.
Target
Human MAPKAPK2 / MAPKAP Kinase 2
Synonyms
MAPKAPK2 | MK-2 | MAP KAP Kinase 2 | MAPKAP kinase 2 | MK2 | MAPKAP-K2 | MAPKAPK-2
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Alkaline Phosphatase
Purification
Affinity purified
Immunogen
A phospho specific peptide corresponding to residues surrounding T334 of human MAPKAPK2.
Specificity
Human MAPKAPK2 / MAPKAP Kinase 2 pThr334
Applications
- Western blot (1:500 - 1:2000)
Presentation
PBS, pH 7.3, 0.02% Sodium Azide, 50% Glycerol
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About MAPKAPK2 / MAPKAP Kinase 2
Featured Products
Species:
Human, Mouse, Rat
Applications:
Western blot, ELISA
Species:
Human
Applications:
IHC, Western blot, Immunoprecipitation, ELISA, Dot Blot
Species:
Human, Monkey, Mouse, Rat, Bovine, Dog, Rabbit, Chicken, Zebrafish
Applications:
IHC, Western blot
Species:
Human, Mouse, Rat
Applications:
Immunofluorescence, Western blot
Species:
Human, Mouse, Rat
Applications:
IHC, Western blot, Immunoprecipitation, ELISA
Reactivity:
Human, Mouse, Rat
Range:
Positive/Negative
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 6/2/2024